Combined drug design of potential Mycobacterium tuberculosis and HIV-1 inhibitors: 3’,4’-di-substituted -4'H-spiro[isothiochromene-3,5'-isoxazol]-4(1H)-one

Documenti analoghi

• Synthesis and antitubercular activity of spiroheterocycles: 2,2’,4’,5’-tetra-substituted-1,2,2',4'-tetrahydro-4H-spiro[isoquinoline-3,3'-pyrazol]-4-ones
  di: Taibi Ben Hadda, et al.
  Pubblicazione: (2007-09-01)
• Combined drug design of potential Mycobacterium tuberculosis and HIV-1 inhibitors: 3’,4’-di-substituted -4'H-spiro[isothiochromene-3,5'-isoxazol]-4(1H)-one
  di: B. Bennani, et al.
  Pubblicazione: (2007-11-01)
• Drug design of new antitubercular agents: 1,3-dipolar cycloaddition reaction of arylnitriloxides and 3-para-methoxy-benzylidene-isochroman-4-ones
  di: Ghali Al Houari, et al.
  Pubblicazione: (2008-03-01)
• 4′-Methyl-3-(4-nitrophenyl)-4-phenyl-4,5,1′,2′,3′,4′-hexahydrospiro[isoxazole-5,2′-naphthalen]-1′-one
  di: Helen Stoeckli-Evans, et al.
  Pubblicazione: (2008-02-01)
• 4-tert-Butyl-3′,4′-bis(4-methylphenyl)-3,4-dihydro-1H,4′H-spiro[naphthalene-2,5′-[1,2]oxazol]-1-one
  di: Mohamed Akhazzane, et al.
  Pubblicazione: (2011-07-01)